SABS Q1 2026 Earnings Widening Losses Amid PreRevenue Status Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution STC Q1 2026 Earnings EPS Surges 485 Above Estimates Title Insurance Momentum Drives Strong Beat ANRO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline ANTA Q1 2026 Earnings Significant EPS Miss Amid Challenging Operating Environment TMC Q1 2026 Earnings Narrowerthanexpected loss as company progresses towards deepsea mining production